ADAP - Adaptimmune Non-GAAP EPS of -$0.05 beats by $0.24 revenue of $5.54M misses by $3.16M August, 04 2022 07:35 AM Adaptimmune Therapeutics plc Adaptimmune press release ( NASDAQ: ADAP ): Q2 Non-GAAP EPS of -$0.05 beats by $0.24 . Revenue of $5.54M (+78.7% Y/Y) misses by $3.16M . For further details see: Adaptimmune Non-GAAP EPS of -$0.05 beats by $0.24, revenue of $5.54M misses by $3.16M